Pharmacokinetics and selected pharmacodynamic effects of tramadol following intravenous administration to the horse
Authors:
- 8 October 2012
- journal article
- research article
- Published by Wiley in Equine Veterinary Journal
- Vol. 45 (4) , 490-496
Abstract
Summary: Reasons for performing study: Both the potential analgesic effect and the conflicting reports describing tramadol disposition in the horse warrant further study of the pharmacokinetics of tramadol in this species. Objectives: To describe the pharmacokinetics of tramadol and its metabolites, O ‐desmethyltramadol and N ‐desmethyltramadol, following i.v. administration of 3 doses to the horse. Methods: Nine adult horses received a single i.v. dose of 0.5, 1.5 and 3 mg/kg bwt tramadol. Blood samples were collected prior to and at various times up to 72 h post administration. Plasma samples were analysed using liquid chromatography‐mass spectrometry and data analysed using noncompartmental analysis. Chin‐to‐ground distance, heart rate and rhythm, step count and gastrointestinal activity were also assessed. Results: Maximal measured plasma tramadol concentrations were 454 ± 101.6, 1086.7 ± 330.7 and 1697.9 ± 406.1 ng/ml for 0.5, 1.5 and 3 mg/kg bwt, respectively. Depending on the dose administered, the tramadol clearance, volume of distribution and half‐life ranged from 24.6 to 25.0 ml/min/kg, 2.66 to 3.33 l/kg and 2.17 to 3.05 h, respectively. Following administration of 0.5, 1.5 and 3 mg/kg bwt tramadol, the maximal measured plasma concentrations of the active metabolite, O ‐desmethyltramadol, were 3.9 ± 1.9, 9.6 ± 4.8 and 12.9 ± 5.2 ng/ml, respectively. Muscle fasiculations and tremors were seen following administration of the 2 high doses. No significant changes in chin‐to‐ground distance, heart rate and rhythm, step count and gastrointestinal activity were observed. Conclusions and potential relevance: This study confirms and extends previous studies describing the pharmacokinetics of tramadol following i.v. administration to the horse. Plasma tramadol concentrations exceeded those necessary for analgesia in human patients; however, further studies are necessary to determine plasma concentrations of tramadol necessary for analgesic efficacy in the horse. These results support further investigation of the analgesic efficacy of tramadol in the horse.Keywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of tramadol and metabolites O-desmethyltramadol and N-desmethyltramadol in adult horsesAmerican Journal of Veterinary Research, 2011
- Determination of oral tramadol pharmacokinetics in horsesResearch in Veterinary Science, 2010
- Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogsThe Veterinary Journal, 2010
- Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horsesVeterinary Anaesthesia and Analgesia, 2009
- Modelling the pharmacokinetics of tramadol: On the difference between CYP2D6 extensive and poor metabolizersJournal of Theoretical Biology, 2008
- Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administrationJournal of Veterinary Pharmacology and Therapeutics, 2007
- Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose AdministrationJournal of Equine Veterinary Science, 2007
- Effects of buprenorphine on nociception and spontaneous locomotor activity in horsesAmerican Journal of Veterinary Research, 2007
- Morphine-6-GlucuronideClinical Pharmacokinetics, 2001
- Postoperative Patient-Controlled Analgesia with Tramadol: Analgesic Efficacy and Minimum Effective ConcentrationsThe Clinical Journal of Pain, 1990